Allergic reactions have anti-cancer properties

  Allergies are something that annoys many people, but there are 2 sides to any situation, and it has a good side. A new study from the UK shows that allergic reactions can be used by the body’s tissues to hypersensitize, so if you think about a possible decreased risk of cancer when plagued by allergies, you might be in a better mood.   Researchers at King’s College London and other institutions reported in the new issue of the American journal Science that they observed the response characteristics of epithelial cells in experimental mice when they were potentially harmed by cancer-causing factors. Epithelial cells are cells located on the surface of organs, and they are often at risk from carcinogenic factors, such as ultraviolet light exposure to epithelial cells on the exterior of the skin and smoking to epithelial cells in the lungs.  British researchers found that epithelial cells threatened by these cancer-causing factors will release a special molecule that activates surrounding immune cells, allowing them to destroy a potentially cancerous epithelial cell. At the same time, however, the immune tissues in the rest of the body are activated by this molecule and the entire immune system begins to release a large number of antibodies, in the same way that happens when the body is allergic.  In the case of allergies, the immune system reacts to remove pollen and other allergens that enter the body, while in the case of cancer “motivation”, the immune system reacts to completely remove toxins that are produced by threatening factors and can cause cancer, reducing the risk of cancer.  The study’s leader, Adrian Heidi, said that the discovery reveals that the immune system is not only motivated to fight cancer, but also to completely remove the toxins that can cause cancer due to threatening factors. Professor Heidi said that this discovery reveals a new way of fighting cancer in the body’s tissues, and that it is possible to explore whether this mechanism can be incorporated into existing cancer treatments to enhance the effectiveness of cancer treatment.